Q4 2019 Bayer AG Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the Bayer's investor and analyst conference call on the full year and fourth quarter 2019 results. (Operator Instructions)
I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead.
Great. Thank you, Haley. Good afternoon, and thanks, everybody, for joining us today. I'd like to welcome all of you to our full year and fourth quarter 2019 conference call.
With me on the call today are Werner Baumann, our CEO; and Wolfgang Nickl, our CFO. And the businesses are represented by the responsible Management Board members. So for pharma, we have Stefan Oelrich. For Consumer Health, we have Heiko Schipper. And for Crop Science, we have Liam Condon.
Werner will begin today's call with an overview of the key developments and performance of the divisions, and Wolfgang will then cover the financials for the full year and the fourth quarter as well as the outlook and some key
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |